Director, Oncology Program Management - Global Asset Lead

Jazz Pharmaceutical; Penn (Westmoreland County); On-site; USD 192,000 - 288,000; Full time

Benefits offered by this job

Medical insurance

Dental insurance

Vision insurance

401k plan

Flexible vacation

Job summary

Jazz Pharmaceuticals is seeking a Director of Project Management to serve as the COO of the asset, guiding cross-functional teams and aligning indications across an integrated program. The role demands senior operational leadership in oncology development, with a focus on strategy, risk management, and executive communication.

You will lead multiple PMs, optimize timelines, and manage dependencies across regulatory filings and late-stage development while partnering with finance and resource

Qualifications

• Experience in biopharmaceuticals/biotechnology with cross-functional R&D PM leadership.
• Proven drug development lifecycle experience from early development to regulatory approvals and launch.
• Experience delivering late-stage registrational programs (Phase 2b/Phase 3) and preparing major health authority filings.

Responsibilities

• Lead asset strategy and translate clinical plans into executable program plans.
• Direct multiple PMs and sub-teams to align milestones and resources.
• Shape executive-level risk/benefit analyses and decision-ready scenarios.

Skills

Cross-functional leadership

Program management

Executive communication

Strategic planning

Timeline optimization

Education

Bachelor's degree in Life Sciences/Engineering/Business

Advanced degree preferred

Tools

Planisware

Smartsheet

Oracle

Job description

Jazz Pharmaceuticals is seeking a Director of Project Management to serve as the COO of the asset, guiding cross-functional teams and aligning indications across an integrated program. The role demands senior operational leadership in oncology development, with a focus on strategy, risk management, and executive communication.

You will lead multiple PMs, optimize timelines, and manage dependencies across regulatory filings and late-stage development while partnering with finance and resource